5-HT2C receptor modulation and the treatment of obesity

被引：36
|
作者：
Bickerdike, MJ [1 ]
Vickers, SP [1 ]
Dourish, CT [1 ]
机构：
[1] Cerebrus PLC, Wokingham RG41 5UA, England
来源：
DIABETES OBESITY & METABOLISM | 1999年 / 1卷 / 04期
关键词：
D O I：
10.1046/j.1463-1326.1999.00037.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：207 / 214
页数：8
相关论文
共 50 条
  • [31] The effects of antipsychotics with 5-HT2C receptor affinity in behavioral assays selective for 5-HT2C receptor antagonist properties of compounds
    Prinssen, EPM
    Koek, W
    Kleven, MS
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 388 (01) : 57 - 67
  • [32] Characterizing the effects of 5-HT2C receptor ligands on motor activity and feeding behaviour in 5-HT2C receptor knockout mice
    Fletcher, Paul J.
    Tampakeras, Maria
    Sinyard, Judy
    Slassi, Abdelmalik
    Isaac, Methvin
    Higgins, Guy A.
    NEUROPHARMACOLOGY, 2009, 57 (03) : 259 - 267
  • [33] Discovery of APD356: A potent and selective 5-HT2C receptor agonist for the treatment of obesity.
    Smith, B
    Smith, J
    Chen, R
    Covel, J
    Dosa, P
    Estrada, S
    Gilson, C
    Park, D
    Prieto, E
    Schultz, J
    Tsai, J
    Webb, R
    Aytes, S
    Burbaum, B
    Fritch, J
    Sengupta, D
    Henshilwood, J
    Saldana, HR
    Thomsen, W
    Whelan, K
    Menzaghi, F
    Bjenning, C
    Martin, M
    Chapman, D
    Maffuid, P
    Beeley, N
    Chalmers, D
    Behan, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U57 - U57
  • [34] MEDI 406-Design, SAR and in vivo evaluation of 5-HT2C receptor agonists for the treatment of obesity
    Wacker, Dean A.
    Varnes, Jeffrey G.
    Miller, Keith J.
    Ung, Thao
    Wu, Ginger
    Hung, Chen-Pin
    Malmstrom, Sarah
    Zhang, Ge
    Otanyi, Eva
    Keim, William J.
    Cullen, Mary Jane
    Rohrbach, Kenneth W.
    Qu Qinling
    Narayanan, Rangaraj
    Rossi, Karen
    Pelleymounter, Mary Ann
    Robl, Jeffrey A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [35] Modulation of 5-HT2A receptor-mediated head-twitch behaviour in the rat by 5-HT2C receptor agonists
    Vickers, SP
    Easton, N
    Malcolm, CS
    Allen, NH
    Porter, RH
    Bickerdike, MJ
    Kennett, GA
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 69 (3-4) : 643 - 652
  • [36] Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonists
    Berg, KA
    Maayani, S
    Goldfarb, J
    Clarke, WP
    ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS, 1998, 861 : 104 - 110
  • [37] Positive-allosteric modulation of the 5-HT2C receptor: implications for neuropsychopharmacology and neurotherapeutics
    Jia Zhou
    Kathryn A. Cunningham
    Neuropsychopharmacology, 2019, 44 : 230 - 231
  • [38] Positive-allosteric modulation of the 5-HT2C receptor: implications for neuropsychopharmacology and neurotherapeutics
    Zhou, Jia
    Cunningham, Kathryn A.
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (01) : 230 - 231
  • [39] Modulation of 5-HT2A and 5-HT2C receptor expression levels by fluoxetine in a genetic mice model of depression
    Bjork, K.
    Zhang, X.
    El Yacoubi, M.
    Vaugeois, J.
    Svenningsson, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S375 - S376
  • [40] Biophysical identification of the 5-HT2A receptor: 5-HT2C receptor interaction in vitro
    Felsing, Daniel Eric
    Anastasio, Noelle C.
    Miszkiel, Joanna M.
    Gilbertson, Scott
    Moeller, Frederick Gerrard
    Allen, John A.
    Cunningham, Kathryn A.
    FASEB JOURNAL, 2018, 32 (01):
12345